INTRODUCTION
The rate of dissolution of a solid is a function of its solubility that influences the absorption of relatively insoluble drugs 1 . In general, it can be stated that the rate of absorption and hence the onset of action is determined by the dissolution of the drug and subsequent transport over the intestinal membrane and passage through the liver. According to the Biopharmaceutical Classification System (BCS), four different types of drug absorption regimes are distinguished 2 . SIM is class II drug 14 . Solubility is generally expressed as the number of grams of solute in one litre o f saturated solution 3. The solute mo lecule is pulled into solution when the force overcomes the attractive force between the solute molecule and its neighboring solute molecule 4 . The positive ion of the solute is attracted to the negative end of the solvent mo lecule 5 . As the particle size reduces the surface area of the solute particle increases and the solute dissolves more rapidly 6 . pH of the mediu m also effect solubility of weak acidic and basic drugs 7 . The amorphous form of a compound is always more soluble than a corresponding crystal form 8 . Very weakly acidic or basic drugs may require a pH that could fall outside the accepted tolerable physiological range or may cause stability problems with formulat ion ingredients 9 . If a drug is poorly soluble, then it will only slowly dissolve, perhaps leading to incomplete absorption 10, 11 . Poor aqueous solubility leads to poor dissolution and ultimately poor oral bioavailability 12, 23 .Many methods such as particle size reduction, soliddispersion, salt formation have mainly used for solubility, dissolution and bioavailability enhancement of poorly aqueous soluble drugs. All these techniques have some limitat ions 13, 20 . The Particle size reduction method produces small particles having larger surface area so enhance absorption and dissolution but the small particles having limitation for wettability and flow properties 15 . Solid dispersion method having limitation because the method of preparation is tough 16, 17 , change in the physicochemical property of materials wh ich is not reproducible 18 ; large scale manufacturing processes and dosage form development is very difficult 19, 24 . So, Physical mixture method, co-grinding method, spray drying method were compared for solubility enhancement of simvastatin as these methods requires less money. Here the natural polymer CHI co mpared with synthetic polymer HPM CE3LV for solubility enhancementment of SIM to provide cost effective formulat ion.
MATERIAL AND MET HOD

Material
Drug Simvastatin ,Chitosan(CHI) were procured fro m Artimis biotech, Hyderabad . Hydroxy propyl methyl cellu lose (HPMCE3LV) was procured from Colo rcon Asia Ltd., Goa. All other chemicals used were of analytical grade.
Drug -Exci pient i nteraction study
The pure drug (SIM ), a mixtures of SIM with HPMCE3LV and SIM with chitosan(CHI) are mixed separately with IR grade KBr in the rat io of 100:1. The pellets were then scanned over a wave range of 4000-400cm -1 in FTIR instrument. 21 Physical mixture o f drug and polymers were prepared in different ratio such as 1:1 to 1:9 w/w. Simp ly poly mer and drug were taken in polyethylene bag and bag was thoroughly vibrated by hand for proper mixing 21 .
Preparation of physical mixture
Preparation of co-grinding mixture 22 Co-grinded mixture of drug and polymers were prepared in different ratio such as 1:1 to 1:9 w/ w. It was co-grinded for 5min, in ceramic mo rtar and sieved through 100 # mesh.
The solvent evaporation of SIM with Ch itosan solution in ratio (1:1, 1:2, 1:6, 1:9 w/ w) was carried out by using spray dryer (LU-222, Advanced, Labult ima, India). The solutions prepare by dissolving 1g of drug in 40 ml of methanol and 1g of Chitosan in 1% acet ic acid and mixed both solutions which produces clear solution. The solvent evaporated at inlet 120 o C and outlet 80 o C , feed pump speed 10 ml per minute and aspiration 45 %.
The solvent evaporation of SIM with HPM CE3LVsolution in ratio (1:1, 1:2, 1:6, 1:9 w/w) was carried out by using spray dryer (LU-222, Advanced, Labult ima, India). The solutions prepare by dissolving 1g of drug in 70 ml of methanol and 1g of HPM CE3LVin 30 ml of distilled water and mixed both solutions which produces clear solution. The solvent evaporated at inlet 120 o C and outlet 80 o C, feed pump speed 10 ml per minute and aspiration 45 %.
Solubility study
The solubility was determined in pH 1.2 HCl buffer, and 7 pH buffer. The solubility of drug, and mixtu re were determined by taking an excess amount 30 mg of drug and added them in 10 ml of above solvents, in teflon facing screw capped vials. The samp les were kept at equilibriu m for a period of 48 hr on orbital shaking incubator at 37 ± 0.5 o C and 50 rp m. The content of vials were filtered through 0.2 micron filter, and analy zed by UV-Vis ible spectrophotometer at 238 n m.
Differential Scanning Calori metry (DSC)
Analysis of samples was carried out on DSC instruments at heating rate of 10 0 C /min. The measurements were performed at a heating range of 10 to 350 0 C under nitrogen pressure.
X-Ray Diffraction studies (XRD)
X-ray diffract ion patterns of samples were obtained using Philips diffractometer and Cu-Kα line as a source of radiation which was operated at the voltage 40 kV and the current 30 mA.
Scanning Electron Microscopy (S EM)
The morphology of samp les was determined using scanning electron microscope (SEM).
Preparation of i mmediate release tablet
All co-grinded mixtures equivalent to 10 mg of SIM was mixed with excip ients for 10 minutes in porcelain mo rtar, passed through 60 # sieve. Th is blend was mixed with magnesiu m stearate for 5 minutes and processed for direct compression by using 7mm round flat -faced punch of rotary tablet machine (Rimek mini press -1). 
Drug content
Simvastatin content in the methanolic extract was analyzed spectrophotometrically at 238 n m, against the standard methanolic solution of simvastatin.
Dissolution Test
Dissolution test of tablets were performed using pH 1.2 HCl buffer and pH 7 buffer with USP d issolution apparatus II at 50 rp m and 37 ± 0.5 0 C. Test samples (5 ml)
were withdrawn at particular time interval (5, 10, 15, 20 and 30 minutes) and replaced with fresh dissolution media maintained at 37 ± 0.5 0 C. The test samples were filtered and the concentration of dissolved drug was determined using UV spectrophotometer at λ max 238 n m.
Stability Study
The accelerated stability study of co-grinding mixture tablet was checked for stability as per ICH guidelines at 40 0 C/75% RH up to 3 months. 
RES ULT AND DISCUSSION
HPM C having surfactant activity 1 which reduces the contact angle and increases wetting of drug particles, thus enhance the solubilisation and dissolution of drug particles. It is reported that the swelling of polymers influences improvement of dissolution rate of poorly aqueous soluble drugs 2 .So preferred less swelling and less viscosity polymers. Due to the less toxic effect, biodegradable nature and low production cost these polymers mainly used as drug carrier in Pharmaceutical industry.
Drug-Exci pient Interaction
Drug-excipient interaction checked using FTIR spectrophotometer. The characteristic peaks found in SIM. These peaks also found in drug-polymer mixture, which indicates no drug-excipient interaction. Solubility data for SIM, PMSHPM C (Physical mixture of SIM and HPM C), CGSHPM C (Co grounded mixture of SIM and HPMC), SDSHPM C (Spray dried mixture of SIM and HPMC), in different solvents are given in Table 6 ,7,8. ANOVA (P<0.001) perfo rmed on solubility parameter demonstrated significant difference between solubility of SIM with co-grinded mixtures. Solubility data of PMSHPM C, CGSHPM C, SDSHPM C shows that ratio 1:6 shows highest solubility. Hence co-grinding mixture is optimized for further processing as it shows good solubility enhancement.
Differential Scanning Calori metry (DSC)
Results of DSC studies are given in fo llowing figures.
Figure 1: DSC thermogram of S IM, CHI, CGSCHI
SIM was characterised by sharp melting endothermic peak at 140.63 0 C.CHI shows broad endothermic peak at 90.08 0 C .CGSCHIshows less intensity of the peak which indicate the conversion of crystalline SIM to amorphous. SIM was characterised by sharp melting endothermic peak at 140.63 0 C. HPM C shows broad endothermic peak at 71.97 0 C. CGSHPM C shows less intensity of the peak which indicate the conversion of crystalline SIM to amorphous. 
Scanning Electron Microscopy (S EM)
The morphological characteristic of drug and processed drug polymer co mplex was shown in fo llo wing figures. 
Dissolution efficiency (DE)
The dissolution profile of tablets in 1.2 pH HCl buffer and 7 pH buffer are g iven in Tab le. The d issolution of cogrinded mixture tablets were compared to that of marketed tablet (MKT) and SIM. Dissolution efficiency was calculated by using software PCP-Disso-v3. ANOVA performed on the dissolution efficiency (DE) of SIM, marketed tablet. Significant difference was found between co-grinded mixture tablets (F4), marketed tablet and SIM. This indicates, the dissolution rate of SIM improved in presence of CHI,HPM C. Tablets of CGSCHI,CGSHPMC have shown better solubility and dissolution enhancement. 
Stability Study
Accelerated stability studies were performed at 40 0 C/75% RH as per the ICH guidelines. Based on the results of initial characterization CGSCHI (F4) , CGSHPM C (F8) are thought to be the superior fo rmulat ion and hence further subjected to accelerated stability study. There was insignificant decrease in dissolution rate of SIM over the period of 3 months. Dissolution profile (DE 30 ) of optimized batches before and after stability is given in Table. 
CONCLUS ION
The present work successfully demonstrated the use of CHI and HPMCE3LV, a low viscosity grade of HPMC polymers as solubility enhancing material. Solubility enhancing properties of CHI and HPM CE3LV were established by solubility studies and confirmed with dissolution studies. Characterization of solid mixtures of drug with poly mer such as DSC, XRD and SEM studies supported the results. The crystalline state of the drug was converted successfully into amorphous state by physical mixing, co-grinding and sprays drying the drug with polymer. But co-grinding shows the best solubility enhancing capacity. CHI shows better solubility enhancement as compare to HPMCE3LV.The natural polymers having surfactant activity that enhances the solubility and dissolution rate of drug. This natural polymers having advantage over other synthetic polymeras this polymers are bioco mpatible, biodegradable and having low cost.
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